Antibiotics to treat Community-acquired Lower Respiratory Tract Infections: mechanism of action, spectrum, epidemiology resistance. S.Malhotra (Antwerp, Belgium)
| |
The science behind rapid diagnostics development for CA-LRTI T. Bachmann (Edinburgh, United Kingdom)
| |
Systematic reviews of diagnostic study M. Leeflang (Amsterdam, The Netherlands)
| |
Introduction in health economics T. van Asselt (Groningen, The Netherlands)
| |
Health economics of diagnostics S. van der Pol (Groningen, The Netherlands)
| |
Diagnostic development and its link to pharma J. Villacian (Janssen Pharmaceutica)
| |
Using qualitative methods to explore the implementation of diagnostics in primary care S. Tonkin Crine (Oxford, Unided Kingdom) , S. Anthierens (Antwerp, Belgium)
| |
Use of machine learning to develop algorithm: advantages and limitations for clinical practice A. Górska (Verona, Italy)
| |
Adaptive Clinical Trial design and process Chris Butler (Oxford, Unided Kingdom), B. Saville (Berry Consultants)
| |
VALUE-Dx communication workshop M. Hoste(Antwerp, Belgium), D. Pazzola (Antwerp, Belgium)
| |